US 12345709
CLAUDIN18 antibodies and methods of treating cancer
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12345709 (CLAUDIN18 antibodies and methods of treating cancer) held by The Regents of the University of California expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K47/68031, A61K47/6849